启明医疗-B发布中期业绩 股东应占亏损1.35亿元 同比收窄34.7%

Group 1 - The core viewpoint of the article is that Qiming Medical-B (02500) reported a decline in revenue and a reduction in shareholder losses for the six months ending June 30, 2025 [1] Group 2 - The company's revenue for the period was RMB 187 million, representing a year-on-year decrease of 18.9% [1] - The loss attributable to shareholders was RMB 135 million, which is a year-on-year narrowing of 34.7% [1] - The loss per share was RMB 0.31 [1]